Plain-language overviews of the compounds in the Rogue Compounds catalog: what each one is, how it was discovered, what published studies have looked at, where the evidence stops, and its regulatory status. Every overview cites peer-reviewed papers you can check on PubMed.
BPC-157 + TB-500 Blend: Research Overview
BPC-157 + TB-500 blend research overview: the separate tendon, wound and vascular studies, the 2026 rat combination study, and the limits of the evidence.
Read overview →CJC-1295 (No DAC) + Ipamorelin: Research Overview
CJC-1295 no DAC + ipamorelin research overview: GHRH receptor and ghrelin receptor agonists, why they are studied together, and where evidence stops.
Read overview →CJC-1295 (No DAC): Research Overview
CJC-1295 without DAC (Modified GRF 1-29): its four substitutions, GHRH receptor signaling, how it differs from DAC, and the research.
Read overview →CJC-1295 with DAC: Research Overview
CJC-1295 with DAC research overview: albumin-binding design, GHRH receptor signaling, GH pulsatility and knockout mouse studies, and evidence gaps.
Read overview →GHK-Cu: Research Overview
GHK-Cu research overview: the plasma copper tripeptide, copper binding chemistry, fibroblast matrix studies, gene-data analyses and evidence limits.
Read overview →GLOW Blend (GHK-Cu, BPC-157, TB-500): Research Overview
GLOW blend research overview: what separate studies on GHK-Cu, BPC-157 and TB-500 cover, the one combination study, and where the evidence stops.
Read overview →Glutathione: Research Overview
Glutathione research overview: gamma-glutamyl structure, synthesis, GSH/GSSG redox cycling, peroxidases, transferases and lab uses.
Read overview →IGF-1 DES: Research Overview
IGF-1 DES (des(1-3)IGF-1): the natural truncated form from colostrum and brain, the missing Gly-Pro-Glu, low IGFBP affinity and the research gaps.
Read overview →IGF-1 LR3: Research Overview
IGF-1 LR3 (Long R3 IGF-1): the 13-residue extension, the Arg3 swap, low IGFBP binding, animal-model findings and what the evidence does not show.
Read overview →Kisspeptin-10: Research Overview
Kisspeptin-10, the KISS1R-activating decapeptide: discovery, GnRH signaling, puberty genetics, and research on glucose homeostasis and tumor biology.
Read overview →KLOW Blend (GHK-Cu, BPC-157, TB-500, KPV): Research Overview
KLOW blend research overview: what the separate studies on GHK-Cu, BPC-157, TB-500 and KPV cover, the one combination study, and where evidence stops.
Read overview →Methylene Blue: Research Overview
Methylene blue: history from dye to lab tool, redox chemistry, mitochondrial and MAO-A research, neuroprotection models and regulatory status.
Read overview →MT-1 (Melanotan 1): Research Overview
Melanotan 1 (afamelanotide) research overview: the 1980 alpha-MSH analog, MC1R pharmacology, cell models and regulatory history.
Read overview →MT-2 (Melanotan II): Research Overview
Melanotan II research overview: cyclic lactam design, melanocortin receptor pharmacology, rodent models, synthesis and regulatory status.
Read overview →PE-22-28: Research Overview
PE-22-28, a spadin-derived TREK-1 channel inhibitor: origin from sortilin, electrophysiology, mouse model studies and evidence limits.
Read overview →PT-141 (Bremelanotide): Research Overview
PT-141 (bremelanotide) research overview: melanotan II origin, melanocortin receptor pharmacology, rodent models and FDA history.
Read overview →Selank: Research Overview
Selank, a tuftsin-derived heptapeptide: origin, enkephalinase inhibition, monoamine and BDNF studies in rodents, and gaps in the evidence.
Read overview →Semax: Research Overview
Semax, the ACTH(4-10)-derived heptapeptide: design, BDNF and TrkB studies, monoamine research, peptide stability and the limits of the evidence.
Read overview →Sermorelin: Research Overview
Sermorelin (GHRH 1-29) research overview: discovery of GHRH, why the 1-29 fragment matters, GHRH receptor signaling, history and regulatory status.
Read overview →TB-500 (Thymosin Beta-4): Research Overview
TB-500 and thymosin beta-4 explained: the 43-residue peptide vs. the 17-23 fragment, actin biology, preclinical models and WADA status.
Read overview →Tesamorelin: Research Overview
Tesamorelin (TH9507) research overview: full-length GHRH analog with an N-terminal hexenoyl cap, receptor signaling, non-clinical data and status.
Read overview →Thymosin Alpha-1: Research Overview
Thymosin alpha-1 research overview: origin in thymus extracts, TLR and dendritic cell signaling, preclinical models and regulatory status.
Read overview →What Is 5-Amino-1MQ? Research Overview
5-Amino-1MQ, a quinolinium NNMT inhibitor: origin, the SAM and NAD+ enzyme biology behind it, and published adipocyte and mouse research.
Read overview →What Is AOD-9604? Research Overview
AOD-9604 research overview: a modified hGH 177-191 peptide, rodent adipose and beta-3 knockout studies, detection work, and what the evidence lacks.
Read overview →What Is ARA-290 (Cibinetide)? Research Overview
ARA-290 (cibinetide), an EPO-derived 11-amino-acid peptide: design, the EPOR/CD131 innate repair receptor model, and preclinical nerve injury research.
Read overview →What Is BPC-157? Research Overview
BPC-157 research overview: origin, sequence, FAK-paxillin and VEGFR2 findings, tendon and vascular models, evidence gaps and regulatory status.
Read overview →What Is Cagrilintide? Research Overview
Cagrilintide, a long-acting acylated amylin analog: amylin and calcitonin receptor pharmacology, peptide engineering and rodent hindbrain research.
Read overview →What Is DSIP? Research Overview
Delta sleep-inducing peptide (DSIP): discovery, structure, neuroendocrine and mitochondrial studies in animals, and why it remains unresolved.
Read overview →What Is Epithalon? Research Overview
Epithalon (AEDG) research overview: origin from epithalamin, gene-expression hypotheses, fly, rodent and cell studies, and evidence limits.
Read overview →What Is FOXO4-DRI? Research Overview
FOXO4-DRI research overview: the FOXO4-p53 senescence model, D-retro-inverso design, cell and mouse studies, and the limits of the evidence.
Read overview →What Is Ipamorelin? Research Overview
Ipamorelin research overview: Novo Nordisk origin, structure, GHS-R1a signaling, the 1998 selectivity data, rodent models and what the evidence lacks.
Read overview →What Is KPV? Research Overview
KPV (Lys-Pro-Val) research overview: the alpha-MSH fragment, PepT1 uptake, NF-kB findings, mouse colitis models and evidence limits.
Read overview →What Is MOTS-c? Research Overview
MOTS-c, a mitochondrial-encoded 16-residue peptide: discovery, folate-AMPK and nuclear signaling mechanisms, and published cell and rodent research.
Read overview →What Is NAD+? Research Overview
NAD+ explained: history, structure, its roles as redox carrier and sirtuin/PARP/CD38 substrate, and what preclinical research shows and does not.
Read overview →What Is PEG-MGF? Research Overview
PEG-MGF research overview: the IGF-1Ec splice variant, Goldspink's MGF hypothesis, myoblast studies, the IGF-1 receptor debate and evidence gaps.
Read overview →What Is Pinealon? Research Overview
Pinealon (Glu-Asp-Arg) research overview: bioregulator origins, oxidative-stress and rodent studies, DNA-binding hypothesis and limits.
Read overview →What Is SLU-PP-332? Research Overview
SLU-PP-332, a synthetic pan-ERR agonist: origin, ERR receptor biology, and published mouse and cell research in muscle, metabolism and the heart.
Read overview →What Is SS-31 (Elamipretide)? Research Overview
SS-31 (elamipretide), a cardiolipin-targeted tetrapeptide: origin, mitochondrial mechanism, preclinical research models, and current regulatory status.
Read overview →What Is VIP? Research Overview
Vasoactive intestinal peptide (VIP): discovery, VPAC1/VPAC2 receptor signaling, and research in smooth muscle, immunology and circadian biology.
Read overview →What Is YK-11? Research Overview
YK-11, a steroidal partial androgen receptor agonist: FDA SARM warnings, safety signals, WADA status, and the small cell-culture literature.
Read overview →Research use only. Rogue Compounds products are sold strictly for laboratory research. They are not for human or veterinary use, and nothing on these pages is medical advice.